Effects of Neurodynamic and Carpal Bone Mobilization in Mild-to-Moderate Carpal Tunnel Syndrome

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-55
SponsorKutahya Health Sciences University

About this trial

Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy caused by compression of the median nerve at the wrist. Conservative interventions such as splinting and manual therapy are frequently used in individuals with mild-to-moderate CTS. Neurodynamic mobilization and carpal bone mobilization aim to improve neural and soft tissue mobility; however, their comparative effects on clinical outcomes and median nerve morphology are not fully understood.

This interventional, non-randomized clinical study aims to compare the clinical and ultrasonographic effects of neurodynamic mobilization plus splinting, carpal bone mobilization plus splinting, and splinting alone in patients with mild-to-moderate CTS. Ninety-three participants diagnosed with mild-to-moderate carpal tunnel syndrome based on electrodiagnostic criteria will be included. Participants will be allocated into three parallel groups without randomization. All participants will receive a neutral-position wrist splint as standard conservative care.

Two intervention groups will additionally receive either neurodynamic mobilization exercises or carpal bone mobilization techniques administered by a physiotherapist for four weeks. Clinical outcomes and median nerve morphology will be evaluated at baseline and immediately after the intervention period.

The primary outcome is the change in the Boston Carpal Tunnel Questionnaire score. Secondary outcomes include pain intensity, neuropathic pain, functional disability, muscle strength, pressure pain threshold, and ultrasonographic measurements of the median nerve.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of mild-to-moderate carpal tunnel syndrome confirmed by electrodiagnostic testing

CTS symptoms for at least 3 months

Ability to provide informed consent

Disqualifiers

Previous carpal tunnel surgery

Diabetes mellitus or polyneuropathy

Cervical radiculopathy

Pregnancy or breastfeeding

Trial design

Design model

Parallel

Treatments tested in this trial

  • Neurodynamic mobilization

    Other intervention

    Median nerve neurodynamic mobilization exercises performed 5 sessions per week for 4 weeks.

  • Carpal bone mobilization

    Other intervention

    Manual carpal bone mobilization techniques applied 5 sessions per week for 4 weeks.

  • Splint

    Other intervention

    Neutral-position wrist splint used during night-time for 4 weeks.

Treatment groups

93 Participants
are divided into 3 treatment groups
Group A: neurodynamic mobs in addition splintExperimental treatment 2 interventions
Group B: Carpal Bone Mobilization + SplintExperimental treatment 2 interventions
Group C: Splint onlyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Boston Carpal Tunnel Questionnaire (BCTQ) Total Score

Change in Boston Carpal Tunnel Questionnaire (BCTQ) Total Score

Time frame
Baseline to 4 weeks

Secondary outcomes

1

Visual Analog Scale (VAS)

Pain intensity measured using a 10-cm visual analog scale.

Time frame
Baseline to 4 weeks
2

Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)

Change in Neuropathic Pain Score Assessed by Leeds Assessment of Neuropathic Symptoms and Signs (LANSS).

Time frame
Baseline to 4 weeks
3

Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH)

Change in Upper Extremity Disability Assessed by Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH).

Time frame
Baseline to 4 weeks
4

Grip Strength

Change Grip strength measured using a Jamar dynamometer.

Time frame
Baseline to 4 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: